Tag Archives: chemoradiation
Bevacizumab Beneficial in Newly Diagnosed Glioblastoma?
A large study of patients with newly diagnosed glioblastoma multiforme suggests that the addition of bevacizumab (Avastin) and irinotecan (Camptosar) to standard chemoradiation can extend survival (progression and overall survival) by 6 months. Bevacizumab (Avastin) is an inhibitor of vascular … Continue reading
Posted in Cancer, Glioblastma
Tagged Avastin, bevacizumab, camptosar, chemoradiation, glioblastoma multiforme, Irinotecan, progression-free survival, Survival, Temodar, temozolomide
Comments Off on Bevacizumab Beneficial in Newly Diagnosed Glioblastoma?